Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Aplenc

Showing results (41-50 of 254) with videos related to

Pageof 26
Sort By:
Pediatric Blood & Cancer|September 6, 2012
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseDana M Walker, Brian T Fisher, Alix E Seif, et al.
Pediatric Blood & Cancer|November 30, 2012
Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative databaseMarko Kavcic, Brian T Fisher, Kari Torp, et al.
Cancer|May 4, 2021
Electronic symptom monitoring in pediatric patients hospitalized for chemotherapyAllison Barz Leahy, Lisa A Schwartz, Yimei Li, et al.
British Journal of Haematology|July 9, 2003
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemiaRichard Aplenc, Wendy Glatfelter, Peggy Han, et al.
Pediatric Hematology and Oncology|July 15, 2022
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group reportAlexandra M Stevens, Terzah M Horton, Chana L Glasser, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2022
Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML PatientsKevin O McNerney, Katelyn Oranges, Alix E Seif, et al.
Breast Cancer Research : BCR|January 22, 2011
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivorsJun J Mao, H Irene Su, Rui Feng, et al.
Plos One|February 9, 2018
Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemiaKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Cancer Medicine|June 25, 2015
A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropeniaKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Trends in Pharmacological Sciences|March 12, 2021
RNA Dysregulation: An Expanding Source of Cancer Immunotherapy TargetsYang Pan, Kathryn E Kadash-Edmondson, Robert Wang, et al.
Pageof 26

Showing results (41-50 of 254) with videos related to

Sort By:
Pageof 26
Pediatric Blood & Cancer|September 6, 2012
Dexrazoxane use in pediatric patients with acute lymphoblastic or myeloid leukemia from 1999 and 2009: analysis of a national cohort of patients in the Pediatric Health Information Systems databaseDana M Walker, Brian T Fisher, Alix E Seif, et al.
Pediatric Blood & Cancer|November 30, 2012
Assembly of a cohort of children treated for acute myeloid leukemia at free-standing children's hospitals in the United States using an administrative databaseMarko Kavcic, Brian T Fisher, Kari Torp, et al.
Cancer|May 4, 2021
Electronic symptom monitoring in pediatric patients hospitalized for chemotherapyAllison Barz Leahy, Lisa A Schwartz, Yimei Li, et al.
British Journal of Haematology|July 9, 2003
CYP3A genotypes and treatment response in paediatric acute lymphoblastic leukaemiaRichard Aplenc, Wendy Glatfelter, Peggy Han, et al.
Pediatric Hematology and Oncology|July 15, 2022
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group reportAlexandra M Stevens, Terzah M Horton, Chana L Glasser, et al.
Journal of Pediatric Hematology/Oncology|February 24, 2022
Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML PatientsKevin O McNerney, Katelyn Oranges, Alix E Seif, et al.
Breast Cancer Research : BCR|January 22, 2011
Association of functional polymorphisms in CYP19A1 with aromatase inhibitor associated arthralgia in breast cancer survivorsJun J Mao, H Irene Su, Rui Feng, et al.
Plos One|February 9, 2018
Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemiaKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Cancer Medicine|June 25, 2015
A comparison of resource utilization following chemotherapy for acute myeloid leukemia in children discharged versus children that remain hospitalized during neutropeniaKelly D Getz, Tamara P Miller, Alix E Seif, et al.
Trends in Pharmacological Sciences|March 12, 2021
RNA Dysregulation: An Expanding Source of Cancer Immunotherapy TargetsYang Pan, Kathryn E Kadash-Edmondson, Robert Wang, et al.
Pageof 26